Patrick Couture Selected Research

Type 2 Diabetes Mellitus (MODY)

11/2016	Systematic Review of the Association between Dairy Product Consumption and Risk of Cardiovascular-Related Clinical Outcomes.
1/2016	n-3 Polyunsaturated Fatty Acid Supplementation Has No Effect on Postprandial Triglyceride-Rich Lipoprotein Kinetics in Men with Type 2 Diabetes.
9/2014	Effects of sitagliptin therapy on markers of low-grade inflammation and cell adhesion molecules in patients with type 2 diabetes.
7/2013	Eicosapentaenoic and docosahexaenoic acid supplementation and inflammatory gene expression in the duodenum of obese patients with type 2 diabetes.
3/2008	Differential effect of atorvastatin and fenofibrate on plasma oxidized low-density lipoprotein, inflammation markers, and cell adhesion molecules in patients with type 2 diabetes mellitus.
2/2008	Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia.
6/2007	Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrick Couture Research Topics

Disease

37	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 10/2002
20	Insulin Resistance 03/2024 - 03/2003
20	Inflammation (Inflammations) 01/2021 - 12/2005
15	Abdominal Obesity 10/2019 - 08/2003
14	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022 - 02/2002
14	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 01/2007
13	Dyslipidemias (Dyslipidemia) 03/2024 - 10/2003
13	Atherosclerosis 10/2022 - 02/2004
11	Hypertriglyceridemia 11/2018 - 08/2004
10	Body Weight (Weight, Body) 05/2022 - 08/2003
9	Homozygous Familial Hypercholesterolemia 01/2024 - 01/2009
9	Obesity 05/2022 - 03/2003
9	Weight Loss (Weight Reduction) 03/2017 - 10/2003
7	Type 2 Diabetes Mellitus (MODY) 11/2016 - 06/2007
6	Hyperlipidemias (Hyperlipidemia) 03/2024 - 10/2005
6	Overweight 05/2022 - 05/2005
5	Hyperlipoproteinemia Type III (Broad Beta Disease) 10/2022 - 09/2004
4	Xanthomatosis (Xanthoma) 10/2019 - 01/2017
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 06/2004
3	Genetic Risk Score 02/2023 - 01/2019
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2018 - 09/2006
3	Coronary Disease (Coronary Heart Disease) 07/2014 - 03/2003
2	Stroke (Strokes) 01/2024 - 11/2016
2	Abdominal Aortic Aneurysm 01/2021 - 11/2016
2	Chronic Renal Insufficiency 01/2021 - 11/2016
2	Aortic Valve Stenosis (Aortic Stenosis) 09/2020 - 05/2019
2	Hypercholesterolemia 11/2018 - 05/2006
2	Hypertension (High Blood Pressure) 11/2016 - 12/2009
1	Myocardial Infarction 01/2024
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2024

Drug/Important Bio-Agent (IBA)

38	oxidized low density lipoproteinIBA 03/2024 - 03/2003
30	Lipoproteins (Lipoprotein)IBA 03/2024 - 02/2002
28	Triglycerides (Triacylglycerol)IBA 02/2023 - 10/2003
26	LipidsIBA 01/2024 - 03/2003
22	ApolipoproteinsIBA 03/2024 - 10/2003
18	LDL CholesterolIBA 03/2024 - 08/2005
16	CholesterolIBA 10/2022 - 02/2004
15	Apolipoproteins B (ApoB)IBA 03/2024 - 10/2003
12	LDL Receptors (LDL Receptor)IBA 01/2022 - 02/2002
11	Fatty Acids (Saturated Fatty Acids)IBA 03/2024 - 09/2013
11	Insulin (Novolin)FDA Link 05/2021 - 12/2005
8	Apolipoprotein B-100 (Apo B 100)IBA 03/2024 - 05/2004
8	HDL CholesterolIBA 10/2022 - 10/2002
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 03/2003
7	LDL Lipoproteins (beta Lipoproteins)IBA 03/2024 - 07/2005
7	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 09/2014
7	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2019 - 01/2008
6	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 02/2023 - 07/2014
6	VLDL LipoproteinsIBA 10/2022 - 02/2004
6	Biomarkers (Surrogate Marker)IBA 09/2020 - 03/2012
6	Ezetimibe (Zetia)FDA Link 01/2018 - 05/2006
6	Apolipoprotein B-48IBA 06/2017 - 05/2006
5	Lipoprotein(a)IBA 04/2021 - 01/2018
5	Corn Oil (Oil, Corn)IBA 01/2018 - 08/2016
5	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2016 - 01/2007
4	Monounsaturated Fatty AcidsIBA 03/2024 - 11/2016
4	Oleic Acid (Oleate)IBA 01/2018 - 07/2014
4	Docosahexaenoic AcidsIBA 08/2016 - 01/2012
3	Rapeseed OilIBA 01/2019 - 07/2014
3	Proteins (Proteins, Gene)FDA Link 02/2018 - 01/2014
3	Dextran SulfateIBA 02/2018 - 08/2016
3	OilsIBA 01/2018 - 07/2014
3	Fibric Acids (Fibrates)IBA 01/2018 - 02/2008
3	Fish OilsIBA 03/2016 - 07/2013
3	CytokinesIBA 03/2016 - 08/2008
3	Cell Adhesion MoleculesIBA 01/2015 - 03/2008
3	Interleukin-6 (Interleukin 6)IBA 04/2013 - 12/2006
3	IsotopesIBA 08/2008 - 05/2006
3	Fenofibrate (CiL)FDA LinkGeneric 03/2008 - 09/2006
3	Atorvastatin (Lipitor)FDA Link 03/2008 - 03/2003
2	PolyphenolsIBA 01/2021 - 01/2018
2	CitrullineIBA 01/2021 - 01/2020
2	Apolipoproteins E (ApoE)IBA 10/2019 - 02/2002
2	AdiponectinIBA 10/2019 - 08/2008
2	ChylomicronsIBA 11/2018 - 02/2004
2	Plant Oils (Vegetable Oils)IBA 01/2018 - 02/2012
2	CarbohydratesIBA 01/2018 - 01/2017
2	Safflower Oil FDA Link 01/2018 - 07/2014
2	Lipase (Acid Lipase)FDA Link 10/2016 - 12/2006
2	Eicosapentaenoic AcidIBA 08/2016 - 07/2013
2	Trans Fatty AcidsIBA 06/2016 - 02/2012
2	ProteomeIBA 01/2015 - 01/2014
2	HDL LipoproteinsIBA 01/2014 - 09/2006
2	E-SelectinIBA 12/2013 - 12/2005
2	C-Reactive ProteinIBA 04/2013 - 08/2008
2	PPAR alphaIBA 10/2009 - 01/2008
2	Simvastatin (Zocor)FDA LinkGeneric 07/2009 - 02/2002
2	Oxidoreductases (Dehydrogenase)IBA 03/2008 - 02/2008
2	Dietary Fats (Dietary Fat)IBA 06/2006 - 10/2002
2	Apolipoprotein C-IIIIBA 06/2006 - 10/2005
1	Olive OilIBA 03/2024
1	AcidsIBA 03/2024
1	lardIBA 03/2024
1	omega-Chloroacetophenone (Mace)IBA 01/2024
1	Insulin-Like PeptidesIBA 10/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	Unsaturated Dietary FatsIBA 01/2022

Therapy/Procedure

9	Therapeutics 01/2024 - 11/2008
8	Mediterranean Diet 03/2017 - 03/2012
4	Blood Component Removal (Apheresis) 02/2018 - 08/2016